Evaluating the progenitor cells of ovarian cancer: analysis of current animal models

키워드

참고문헌 (89)

1. Jemal, A, "Cancer statistics, 2009", J. Clin, 59, pp.225~249 (2009)
2. Auersperg, N, "Ovarian carcinogenesis and the biology of ovarian surface epithelium", J. Cell. Physiol, 173, pp.261~265 (1997)
3. Bell, D. A, "Origins and molecular pathology of ovarian cancer", Mod. Pathol, 18(Suppl 2), pp.S19~S32 (2005)
4. Gilks, C. B, "Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma", J. Oncol, 2010, pp.740968~ (2010)
5. Shih Ie, M, "Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis", Am. J. Pathol, 164, pp.1511~1518 (2004)
6. Auersperg, N, "Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches", Int. J. Gynecol. Cancer, 12, pp.691~703 (2002)
7. Scully, R. E, "Early de novo ovarian cancer and cancer developing in benign ovarian lesions", Int. J. Gynaecol. Obstet, 49, pp.S9~S15 (1995)
8. Lee, Y, "A candidate precursor to serous carcinoma that originates in the distal fallopian tube", J. Pathol, 211, pp.26~35 (2007)
9. Auersperg, N, "Ovarian surface epithelium: biology, endocrinology, and pathology", Endocr. Rev, 22, pp.255~288 (2001)
10. Burdette, J. E, "Gonadotropin-induced superovulation drives ovarian surface epithelia proliferation in CD1 mice", Endocrinology, 147, pp.2338~2345 (2006)
11. Auersperg, N, "The origin of ovarian carcinomas: a developmental view", Gynecol. Oncol, 110, pp.452~454 (2008)
12. Fathalla, M. F, "Incessant ovulation--a factor in ovarian neoplasia", Lancet, 2, pp.163~ (1971)
13. Wright, J. W, "Induction of proliferation in the primate ovarian surface epithelium in vivo", Hum. Reprod, 23, pp.129~138 (2008)
14. Parrott, J. A, "Expression and actions of both the follicle stimulating hormone receptor and the luteinizing hormone receptor in normal ovarian surface epithelium and ovarian cancer", Mol. Cell Endocrinol, 172, pp.213~222 (2001)
15. Konishi, I, "Review: gonadotropins and development of ovarian cancer", Oncology, 57(Suppl 2), pp.45~48 (1999)
16. Edmondson, R. J, "Gonadotropins mediate DNA synthesis and protection from spontaneous cell death in human ovarian surface epithelium", Int. J. Gynecol. Cancer, 16, pp.171~177 (2006)
17. Chakravarti, S, "Hormonal profiles after the menopause", Br. Med. J, 2, pp.784~787 (1976)
18. Espey, L. L, "Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction", Biol. Reprod, 50, pp.233~238 (1994)
19. Murdoch, W. J, "Ovulatory factor in ovarian carcinogenesis", Adv. Exp. Med. Biol, 622, pp.119~128 (2008)
20. Murdoch, W. J, "Ovulation-induced DNA damage in ovarian surface epithelial cells of ewes: prospective regulatory mechanisms of repair", survival and apoptosis, 2001, pp.65, 1417~1424
21. Burdette, J. E, "Ovarian epithelial inclusion cysts in chronically superovulated CD1 and Smad2 dominant-negative mice", Endocrinology, 148, pp.3595~3604 (2007)
22. Ghahremani, M, "Etiology of ovarian cancer: a proposed mechanism", Med. Hypotheses, 52, pp.23~26 (1999)
23. Roh, M. H, "Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin", Am. J. Surg. Pathol, 33, pp.376~383 (2009)
24. Jarboe, E, "Serous carcinogenesis in the fallopian tube: a descriptive classification", Int. J. Gynecol. Pathol, 27, pp.1~9 (2008)
25. Kindelberger, D. W, "Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship", Am. J. Surg. Pathol, 31, pp.161~169 (2007)
26. Sundfeldt, K, "E-cadherin expression in human epithelial ovarian cancer and normal ovary", Int. J. Cancer, 74, pp.275~280 (1997)
27. Levanon, K, "Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis", Oncogene, 29, pp.1103~1113 (2010)
28. Kurman, R. J, "The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory", Am. J. Surg. Pathol, 34, pp.433~443 (2010)
29. Auersperg, N, "The origin of ovarian carcinomas: a unifying hypothesis", Int. J. Gynecol. Pathol, 30, pp.12~21 (2011)
30. Crum, C. P, "Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer", Clin. Med. Res, 5, pp.35~44 (2007)
31. Press, J. Z, "Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities", BMC Cancer, 8, pp.17~ (2008)
32. Press, J. Z, "Identification of a preneoplastic gene expression profile in tubal epithelium of BRCA1 mutation carriers", Neoplasia, 12, pp.993~1002 (2010)
33. Cass, I, "BRCA-mutation-associated fallopian tube carcinoma: a distinct clinical phenotype", Obstet. Gynecol, 106, pp.1327~1334 (2005)
34. Xian, W, "The Li-Fraumeni syndrome (LFS): a model for the initiation of p53 signatures in the distal Fallopian tube", J. Pathol, 220, pp.17~23 (2010)
35. Alexander, B. M, "Ovarian morphometrics in TP53-deficient mice", Anat. Rec, 290, pp.59~64 (2007)
36. Cooper, T. K, "Spontaneous lesions in the reproductive tract and mammary gland of female non-human primates", Birth Defects Res. B. Dev. Reprod. Toxicol, 80, pp.149~170 (2007)
37. Marr-Belvin, A. K, "Ovarian pathology in rhesus macaques: a 12-year retrospective", J. Med. Primatol, 39, pp.170~176 (2010)
38. Moore, C. M, "Spontaneous ovarian tumors in twelve baboons: a review of ovarian neoplasms in non-human primates", J. Med. Primatol, 32, pp.48~56 (2003)
39. Swisher, E, "Ovarian cancer associated with inherited mutations in BRCA1 or BRCA2", Curr. Womens Health Rep, 3, pp.27~32 (2003)
40. Cline, J. M, "Selected background findings and interpretation of common lesions in the female reproductive system in macaques", Toxicol. Pathol, 36, pp.142s~163s (2008)
41. Rodriguez, G. C, "Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor- beta", J. Natl. Cancer Inst, 94, pp.50~60 (2002)
42. Rodriguez, G. C, "Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis", J. Soc. Gynecol. Investig, 5, pp.271~276 (1998)
43. Lu, K. H, "The monkey, the hen, and the mouse: models to advance ovarian cancer chemoprevention", Cancer Prev. Res, 2, pp.773~775 (2009)
44. Barnes, M. N, "A pilot study of ovarian cancer chemoprevention using medroxyprogesterone acetate in an avian model of spontaneous ovarian carcinogenesis", Gynecol. Oncol, 87, pp.57~63 (2002)
45. Fredrickson, T. N, "Ovarian tumors of the hen", Environ. Health Perspect, 73, pp.35~51 (1987)
46. Barua, A, "Histopathology of ovarian tumors in laying hens: a preclinical model of human ovarian cancer", Int. J. Gynecol. Cancer, 19, pp.531~539 (2009)
47. Hakim, A. A, "Ovarian adenocarcinomas in the laying hen and women share similar alterations in p53, ras, and HER-2", neu, 2009, pp.2, 114~121
48. Nofech-Mozes, S, "Immunophenotyping of serous carcinoma of the female genital tract", Mod. Pathol, 21, pp.1147~1155 (2008)
49. Nowee, M. E, "HER-2", neu and p27Kip1 in progression of Fallopian tube carcinoma: an immunohistochemical and array comparative genomic hybridization study, 2007, pp.51, 666~673
50. Trevino, L. S, "Gene Expression Profiling Reveals Differentially Expressed Genes in Ovarian Cancer of the Hen: Support for Oviductal Origin?", Hormones and Cancer, 1, pp.177~186 (2010)
51. Greenacre, C. B, "Spontaneous tumors of small mammals", Vet. Clin. North. Am. Exot. Anim. Pract, 7, pp.627~651 (2004)
52. Gregson, R. L, "Spontaneous ovarian neoplasms of the laboratory rat", Vet. Pathol, 21, pp.292~299 (1984)
53. Sharrow, A. C, "Identification and characterization of a spontaneous ovarian carcinoma in Lewis rats", J. Ovarian Res, 3, pp.9~ (2010)
54. Komatsu, M, "Electron-microscopic studies on the development and aging of the oviduct epithelium of mice", Anat. Embryol, 152, pp.243~259 (1978)
55. Critoph, F. N, "The cellular composition of the human oviduct epithelium", Br. J. Obstet. Gynaecol, 84, pp.219~221 (1977)
56. Baird, D. T, "Relationship between the secretion of the corpus luteum and the length of the follicular phase of the ovarian cycle", J. Reprod. Fertil, 45, pp.611~619 (1975)
57. Maronpot, R. R, "Ovarian toxicity and carcinogenicity in eight recent National Toxicology Program studies", Environ. Health Perspect, 73, pp.125~130 (1987)
58. Bai, W, "Estrogen stimulation of ovarian surface epithelial cell proliferation", Vitro Cell Dev. Biol. Anim, 36, pp.657~666 (2000)
59. Umezu, T, "Characterization of newly established clonal oviductal cell lines and differential hormonal regulation of gene expression", Vitro Cell Dev. Biol. Anim, 39, pp.146~156 (2003)
60. Ziecik, A. J, "Novel biological and possible applicable roles of LH", hCG receptor, 2007, pp.269, 51~60
61. Tunca, J. C, "Chemical induction of ovarian tumors in rats", Gynecol. Oncol, 21, pp.54~64 (1985)
62. Stewart, S. L, "Characterization of a carcinogenesis rat model of ovarian preneoplasia and neoplasia", Cancer Res, 64, pp.8177~8183 (2004)
63. anthracene (DMBA) coated suture, "Carcinogenesis", 2005, 951~957
64. Wang, Y, "Enhanced susceptibility to chemical induction of ovarian tumors in mice with a germ line p53 mutation", Mol. Cancer Res, 6, pp.99~109 (2008)
65. Jarboe, E. A, "Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma", Mod. Pathol, 22, pp.345~350 (2009)
66. Corney, D. C, "Role of p53 and Rb in ovarian cancer", Adv. Exp. Med. Biol, 622, pp.99~117 (2008)
67. Gowen, L. C, "Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities", Nat. Genet, 12, pp.191~194 (1996)
68. Garson, K, "Models of ovarian cancer--are we there yet?", Mol. Cell Endocrinol, 239, pp.15~26 (2005)
69. Boyd, J, "Mouse models of gynecologic pathology", N. Engl. J. Med, 352, pp.2240~2242 (2005)
70. Buller, R. E, "The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer", Clin Cancer Res, 7, pp.831~838 (2003)
71. Clark-Knowles, K. V, "Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas", PLoS One, 4, pp.e8534~ (2009)
72. Clark-Knowles, K. V, "Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes", Exp. Cell Res, 313, pp.133~145 (2007)
73. Quinn, B. A, "Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53", PLoS One, 4, pp.e8404~ (2009)
74. Flesken-Nikitin, A, "Induction of carcinogenesis by concurrent inactivation of p53 and Rb1 in the mouse ovarian surface epithelium", CANCER RESEARCH, 63(13), pp.3459~3463, AMER ASSOC CANCER RESEARCH
75. Laviolette, L. A, "17beta-estradiol accelerates tumor onset and decreases survival in a transgenic mouse model of ovarian cancer", Endocrinology, 151, pp.929~938 (2010)
76. Tanyi, J. L, "Identification of tissue- and cancer-selective promoters for the introduction of genes into human ovarian cancer cells", Gynecol. Oncol, 85, pp.451~458 (2002)
77. Zhang, Y, "A transgenic FOXJ1-Cre system for gene inactivation in ciliated epithelial cells", Am. J. Respir. Cell Mol. Biol, 36, pp.515~519 (2007)
78. Miyoshi, I, "Mouse transgenic for murine oviduct-specific glycoprotein promoter- driven Simian Virus 40 large T-antigen: tumor formation and its hormonal regulation", Mol. Reprod. Dev, 63, pp.168~176 (2002)
79. Connolly, D. C, "Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer", Cancer Res, 63, pp.1389~1397 (2003)
80. Quinn, B. A, "Development of a syngeneic mouse model of epithelial ovarian cancer", J. Ovarian Res, 3, pp.24~ (2010)
81. Karst, A. M, "Modeling high-grade serous ovarian carcinogenesis from the fallopian tube", Proc. Natl. Acad. Sci. U.S.A, 108, pp.7547~7552 (2011)
82. Chodankar, R, "Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells", Curr. Biol, 15, pp.561~565 (2005)
83. Zheng, W, "Follicle-stimulating hormone receptor is expressed in human ovarian surface epithelium and fallopian tube", Am. J. Pathol, 148, pp.47~53 (1996)
84. Mishina, Y, "High specificity of Mullerian-inhibiting substance signaling in vivo", Endocrinology, 140, pp.2084~2088 (1999)
85. Bristol-Gould, S. K, "The development of a mouse model of ovarian endosalpingiosis", Endocrinology, 146, pp.5228~5236 (2005)
86. Liang, S, "Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation", PLoS One, 4, pp.e4295~ (2009)
87. Mullany, L. K, "Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo", Oncogene (2011)
88. Shayesteh, L, "PIK3CA is implicated as an oncogene in ovarian cancer", Nat. Genet, 21, pp.99~102 (1999)
89. Dinulescu, D. M, "Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer", Nat. Med, 11, pp.63~70 (2005)

관련 논문AI추천